The Trip Report
Un podcast de Beckley Waves
Catégories:
46 Épisodes
-
#42 Reed Finlay: Designing Spaces for Healing and Transformation
Publié: 20/02/2025 -
#41 Josh White: Support & Coaching for Psychedelic Experiences
Publié: 06/02/2025 -
#40 Tom Morgan: Dark Night of the Soul and the Future of Intelligence
Publié: 23/01/2025 -
#39 Gabe Charalambides: Psychedelic Entrepreneurship
Publié: 10/01/2025 -
#38 Hailey Gilmore: The Complexity of Psychedelic Science
Publié: 20/12/2024 -
#37 Dr. James Cooke: The Dawn of Mind: How Matter Became Conscious and Alive
Publié: 12/12/2024 -
#36 Dillan DiNardo: Engineering Consciousness with Psychedelics and AI
Publié: 29/11/2024 -
Special Dispatch: Regulatory Plasticity with Matt Zorn
Publié: 19/11/2024 -
Special Dispatch: An Election Retrospective with Nick Gillespie
Publié: 13/11/2024 -
#35 Lucia Huang: Innovative Solutions in Neuropsychiatry
Publié: 31/10/2024 -
#34 Shamil Chandaria: Computational Neuroscience and Human Flourishing
Publié: 17/10/2024 -
#33 Rock Feilding-Mellen: Building the Future of the Psychedelic Field
Publié: 03/10/2024 -
#32 Rachelle Sampson & Bennet Zelner: The Connected Leadership Study
Publié: 19/09/2024 -
Ep #31 Rebecca Kronman: Psychedelics & Parenting
Publié: 05/09/2024 -
Ep #30 Nick Gillespie: Reflection on the FDA’s Rejection of MDMA Assisted Therapy
Publié: 22/08/2024 -
Special Dispatch: FDA Rejects Lykos’ MDMA Assisted Therapy Application
Publié: 13/08/2024 -
#29 Dr. Selma Holden MD: All Eyes on the FDA
Publié: 08/08/2024 -
#28 East Forest: Music for Mushrooms
Publié: 25/07/2024 -
#27 Joanna Kempner: Psychedelic Outlaws
Publié: 11/07/2024 -
#26 Brandon Kapelow: ‘An Act of Service’- A Journey Through PTSD and Ketamine Therapy
Publié: 27/06/2024
The Trip Report is a podcast and newsletter about the business, science, and policy developments of the evolving psychedelic field. While the main organizing theme is psychedelics, it is really about the many different domains that are converging to bring about this field and the assembly of what many believe to be a “New Paradigm” in science, medicine, and our understanding of the human experience. Our goal is to foster an educated and informed psychedelic ecosystem, and to do that, we will feature in-depth conversations with scientists, entrepreneurs, investors and stakeholders at the forefront of the psychedelic renaissance. www.thetripreport.com
